A detailed history of Pfg Advisors transactions in Novo Nordisk A S stock. As of the latest transaction made, Pfg Advisors holds 4,088 shares of NVO stock, worth $470,610. This represents 0.04% of its overall portfolio holdings.

Number of Shares
4,088
Previous 4,093 0.12%
Holding current value
$470,610
Previous $525,000 11.05%
% of portfolio
0.04%
Previous 0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$122.71 - $146.91 $613 - $734
-5 Reduced 0.12%
4,088 $583,000
Q1 2024

May 06, 2024

BUY
$102.11 - $135.92 $13,376 - $17,805
131 Added 3.31%
4,093 $525,000
Q4 2023

Jan 19, 2024

BUY
$87.78 - $105.45 $347,784 - $417,792
3,962 New
3,962 $409,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $260B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Pfg Advisors Portfolio

Follow Pfg Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfg Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Pfg Advisors with notifications on news.